[DOI] [PMC free article] [PubMed] [Google Scholar] 68.Rabbani N., Al-Motawa M., Thornalley P.J
A major hurdle lies in regulatory classification
PLoS One (2013) 8:e65763
BPC-157 is used to support the treatment of gastroesophageal reflux disease , because thanks to its regulatory abilities, it influences the regulation of pressure inside the esophagus, concerning the lower esophageal sphincter and the pyloric sphincter, which means the peptide can be used both in preventive therapy and as an adjunct in treating gastroesophageal reflux disease, leading to its inhibition and the disappearance of related symptoms
While an impaired BBB might be more sensitive to insults, it is also possible that an increase in LPS-receptors, such as toll-like receptors, seen in animals with -synuclein over-expression, enhances the toxicity of LPS to the BBB [264, 271]
It is a water-soluble vitamin, meaning excess will be flushed out in the urine